• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Non-platinum combination of gemcitabine in NSCLC.

作者信息

Favaretto A G

机构信息

Medical Oncology Department, Azienda Ospedaliera di Padova, Padova, Italy.

出版信息

Ann Oncol. 2006 May;17 Suppl 5:v82-5. doi: 10.1093/annonc/mdj957.

DOI:10.1093/annonc/mdj957
PMID:16807471
Abstract
摘要

相似文献

1
Non-platinum combination of gemcitabine in NSCLC.非铂类吉西他滨联合方案用于非小细胞肺癌治疗
Ann Oncol. 2006 May;17 Suppl 5:v82-5. doi: 10.1093/annonc/mdj957.
2
[Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].铂盐与吉西他滨联合治疗非小细胞肺癌
Bull Cancer. 2002 Aug;89 Spec No:S80-4.
3
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.多西他赛联合吉西他滨或长春瑞滨作为晚期非小细胞肺癌患者二线治疗的每周方案：米妮·珀尔癌症研究网络的II期试验
Cancer. 2001 Nov 1;92(9):2391-8. doi: 10.1002/1097-0142(20011101)92:9<2391::aid-cncr1587>3.0.co;2-m.
4
Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naïve advanced non-small-cell lung cancer in the era of third-generation agents.在三代药物时代，对于化疗初治的晚期非小细胞肺癌，非铂类双药与基于铂类的双药同样有效。
J Cancer Res Clin Oncol. 2013 Jan;139(1):25-38. doi: 10.1007/s00432-012-1294-z. Epub 2012 Aug 5.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
[Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?].[不含铂的吉西他滨联合方案：非小细胞肺癌传统化疗的替代方案？]
Bull Cancer. 2002 Aug;89 Spec No:S85-90.
7
[Gemcitabine].[吉西他滨]
Nihon Rinsho. 2002 May;60 Suppl 5:359-65.
8
Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.二线紫杉醇/卡铂与长春瑞滨/卡铂治疗先前接受非铂类化疗的晚期非小细胞肺癌患者：一项多中心随机 II 期研究。
Clin Lung Cancer. 2011 Mar;12(2):100-5. doi: 10.1016/j.cllc.2011.03.004. Epub 2011 Apr 11.
9
Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer.非小细胞肺癌脑转移患者颅脑放疗后铂类化疗的疗效
Oncol Rep. 2005 Jul;14(1):207-11.
10
Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.长春瑞滨联合吉西他滨序贯多西他赛与卡铂联合紫杉醇治疗晚期非小细胞肺癌患者的随机、开放标签、III期研究
Lancet Oncol. 2008 Dec;9(12):1135-42. doi: 10.1016/S1470-2045(08)70261-4. Epub 2008 Nov 13.

引用本文的文献

1
Synthesis of Gemcitabine-Loaded PLGA Microparticles with Green Solvents.使用绿色溶剂合成载吉西他滨的聚乳酸-羟基乙酸共聚物微粒
ACS Omega. 2025 Jul 24;10(30):33946-33958. doi: 10.1021/acsomega.5c06385. eCollection 2025 Aug 5.
2
A Pharmacokinetic and Pharmacodynamic Evaluation of the Anti-Hepatocellular Carcinoma Compound 4--Carbobenzoxy-gemcitabine (Cbz-dFdC).抗肝癌化合物 4--卡宾苯甲酰基-吉西他滨（Cbz-dFdC）的药代动力学和药效学评价。
Molecules. 2020 May 8;25(9):2218. doi: 10.3390/molecules25092218.
3
Preclinical absorption, distribution, metabolism, and excretion of an oral amide prodrug of gemcitabine designed to deliver prolonged systemic exposure.
一种口服酰胺前药的临床前吸收、分布、代谢和排泄研究，旨在提供延长的全身暴露。
Pharmaceutics. 2013 May 8;5(2):261-76. doi: 10.3390/pharmaceutics5020261.
4
Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.中药分期结合化疗治疗晚期非小细胞肺癌。
J Cancer Res Clin Oncol. 2011 Jul;137(7):1117-22. doi: 10.1007/s00432-011-0975-3. Epub 2011 Feb 5.